|
|
|
| Research Grants |
RAYMOND F. ANTON JR.
Psychiatry and Behavioral
Sciences. Genetic and Brain Mechanisms of Naltrexone’s Treatment
Efficacy for Alcoholism, $508,954 from National Institute on Alcohol
Abuse and Alcoholism, May 2009 through April.
LOUISE HAYNES
Psychiatry
and Behavioral Sciences. HIV Testing and Counseling in STD Clinics: An
Adaptation of CTN 0032, $583,847 from University of Miami, December
2009 through August.
KATHIE HERMAYER
Medicine.
Basal Bolus versus Basal Insulin Regimen for the Treatment of
Hospitalized Patients with Type 2 Diabetes Mellitus: A Randomized,
Open-Labeled, Non-Inferiority Controlled Study (Basal Plus Trial),
$179,116 from Sanofi-Aventis US Inc., November 2009 through November.
MICHAEL J. KERN
Cell
Biology and Anatomy. Biophysical Modeling of Fluid and Solute Transport
in the TMJ, $9,027 from Clemson University, May 2009 through April.
DHANDAPANI KUPPUSWAMY
Medicine.
mTOR in Growth and Protection of Hypertrophying Myocardium, $368,750
from National Heart, Lung and Blood Institute, December 2009 through
November.
CARRIE L. RANDALL
Psychiatry
and Behavioral Sciences. Mentoring and Career Development in Alcohol
Research, $152,250 from National Institute on Alcohol Abuse and
Alcoholism, September 2009 through August.
ADRIAN REUBEN
Medicine. A Multi-Center
Trial to Study Acute Liver Failure: Data and Specimen Collection
Protocol Acute Liver Injury (ALI) and N-Acetylcysteine (NAC), $28,470
from UT Southwestern Medical Center, September 2009 through August.
DAVID RIVERS
Library
Science and Informatics. Corp. Support— National Conference on Health
Disparities, $10,000 from Multiple Sponsors, February 2007 through
December.
SCSU—Environmental Policy Outreach Initiative, $650,000 from SC State University, September 2009 through September 2012.
Corp. Support—National Conference on Health Disparities, $5,000 from Multiple Sponsors, February 2007 through December 2010.
Corp. Support—National Conference on Health Disparities, $10,000 from Multiple Sponsors, February 2007 through December 2010.
STEVEN A. SAHN
Medicine.
Anti-Coagulant Effectiveness in Idiopathic Pulmonary Fibrosis, a
Randomized, Double-Blind, Placebo-Controlled Trial (ACE-IPF), $219,526
from Duke University, December 2009through December 2012.
Prednisone, Azathioprine, N-Acetylcysteine: A Study That Evaluates Responses in Idiopathic Pulmonary Fibrosis (PANTHER-IPF), $182,411 from Duke University, December 2009 through December 2012.
CLAUDIO SCHONHOLZ
Radiology.
Parodi Guidewire Study, $2,500 from Interventional & Surgical
Innovations LLC, October 2009 through October.
RICHARD M. SILVER
CHARLIE STRANGE (CO-PI)
Medicine.
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial
Lung Disease (SLS II), $88,917 from University of California, Los
Angeles, August 2009 through July.
ROBERT K. STUART
Medicine.
Phase 3, Open-Label, Randomized Study of Amonafide L-Malate in
Combination with Cytarabine Compared to Daunorubicin in Combination
with Cytarabine in Patients with Secondary Acute Myeloid Leukemia
(AML), $71,000 from INC Research Inc., September 2008 through December
2013.
AQUILLA S. TURK III
Radiology. Aneurysm and Parent Vessel Occlusion, $36,852 from Nfocus Neuromedical Inc., May 2008 through June.
MICHAEL E. Ullian
Medicine. Role of Angiotensin
II in Peritoneal Sclerosis, $296,379 from Dialysis Clinics Inc.,
December 2009 through November 2012.
YONG WANG
Pathology and Laboratory
Medicine. MicroRNA Expression Signatures as Novel Biomarkers for
Radiation Biodosimetry, $110,625 from Fred Hutchison Cancer Research
Center, August 2009 through July.
DEBORAH WILLIAMSON
Nursing. Video Medical Interpretation Research, $59,345 from National Library of Medicine, September 2009 through September.
Friday, March 11, 2010
|
|
|
